A small scale clinical study to understand safety and effectiveness of Sciatican-50 in patients of sciatica

A pilot, exploratory clinical study to evaluate the safety and efficacy of SciatiCan-50 in the patients with Sciatica. - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/10/075980

Enrollment

Registered

2024-10-28

Start date

Unknown

Completion date

Unknown

Last updated

2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M511- Thoracic, thoracolumbar and lumbosacral intervertebral disc disorders with radiculopathy

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1) Diagnosed patients of Sciatica of age group 20–60 years 2) Patients having positive SLR test on examination and showing any one symptoms of sciatica (leg pain, numbness and tingling sensation in leg, weakness in leg and leg pain or back pain while sitting) 3) Ability to provide informed consent and willingness to comply with study procedures 4) Availability for follow-up assessments throughout the study duration.

Exclusion criteria

Exclusion criteria: 1) Participants taking any other treatment or medications for any pain or inflammation. 2) Participants with a history of spinal surgery within the past six months. 3) Presence of other serious spinal conditions such as spinal tumors, fractures, Pott’s spine, ovarian cyst which compressing sciatica nerve etc. 4) History of severe psychiatric disorders that may affect participation or compliance. 5) Concurrent participation in other clinical trials related to sciatica treatment.

Design outcomes

Primary

Measure	Time frame
To study effects of Sciatican-50 in diagnosed patients of sciatica with Straight leg raise Test, Sciatica Bothersomeness Index and Oswestry test.Timepoint: 4 weeks	—

Secondary

Measure	Time frame
To evaluate the safety and tolerability of the sciatiCan-50 among participantsTimepoint: 4 weeks	—

Countries

India

Contacts

Public ContactDr Ankita Ingole

Dr. D. Y. Patil College of Ayurved and Research Centre, Pimpri, Pune-18

drankitaingole@gmail.com9766588108

Outcome results